EGFR and non-small cell lung carcinoma: Here, we used NGS to examine the predictive and prognostic roles of BIM deletion polymorphisms with respect to the response to first‐, second‐, and third‐generation EGFR‐TKIs in NSCLC patients from two independent cohorts.